London, Jan 18, 2026, 08:10 GMT — Markets have closed.
- Shares of London-listed British American Tobacco closed Friday at 4,326p, slipping roughly 0.3% for the session.
- The U.S.-listed ADR last traded at $58.22, marking a roughly 0.2% gain from its previous close.
- Investors are focused on February results and how quickly BAT will execute its share buyback.
British American Tobacco p.l.c. BATS.L slipped 13 pence, or 0.3%, to finish at 4,326p on Friday, after fluctuating between 4,306p and 4,386p during the day. Across the Atlantic, its ADR (BTI) gained 0.2%, reaching $58.22, on volume of roughly 2.4 million shares traded.
With the London market closed over the weekend, BAT’s shares will reopen Monday as investors wrestle with the true potential of its “smoke-free” ambitions in 2026. The company has bet heavily on nicotine pouches and vapes, yet the key question remains: when will that growth translate into consistent profits?
Just before the close on Dec. 9, BAT flagged that its 2026 results would likely hit the lower end of its mid-term targets, citing tougher competition and tighter U.S. vape regulations. CEO Tadeu Marroco said he was “trying to be cautious for 2026.” Rae Maile from Panmure Liberum called the update “not quite what the share price needed.” Reuters
Buybacks are central to the story. When a company buys back its own shares—usually to cancel them—it can boost earnings per share by reducing the share count. In a December notice on Nasdaq, BAT revealed an irrevocable deal with UBS to buy shares during its closed period from Jan. 2 to Feb. 11, a timeframe before results when company insiders typically can’t trade.
U.S. traders have shown growing interest. A BNK Invest article on Nasdaq Friday highlighted that BTI surpassed an average 12‑month analyst target price of $57.88, according to Zacks data. The stock still carries a mix of bullish and bearish ratings.
That could change quickly. Should enforcement against illicit vapes slip once more, or legal products fail to claw back market share, investors might view the buyback less as a safety net and more as mere financial engineering.
Peer moves are quietly shaping the scene. Imperial Brands, Philip Morris, and Altria all compete for the same shrinking nicotine user base, making pricing and marketing shifts a quick hit to margins.
BAT is set to release its full-year 2025 results on Feb. 12. Investors will be focused on updates to the 2026 outlook and specifics regarding cash returns.
Related articles: LSE:BATS.L
